FN3 Library Assembly for High-Fidelity Therapeutic Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing FN3 libraries for biologics drug discovery suffer from high frequency of unproductive variants due to stochastic mutagenesis, leading to inefficient candidate screens, destabilization, and non-functional proteins, which increase resource consumption and time to identify drug candidates.
Innovation Solution
Construction of FN3 libraries using oligonucleotides with discretely defined sequences, excluding non-conserved amino acid substitutions, to maximize diversity and minimize non-functional proteins, while ensuring high affinity target binding.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If stochastic mutagenesis techniques (random mutagenesis, saturation mutagenesis, error-prone PCR, gene shuffling, or walk-through mutagenesis) are used to create FN3 libraries, then sequence diversity is achieved, but the frequency of unproductive variants increases and screening efficiency decreases
Solution Approach 1:
The patent employs in vitro transcription and translation systems that self-assemble functional FN3 proteins from synthesized oligonucleotide sequences without requiring cellular machinery. This self-service approach eliminates the need for mutagenesis while generating diverse, functional protein variants through controlled oligonucleotide pool design and assembly.
Solution Approach 2:
The patent replaces stochastic chemical/biological mutagenesis processes with a deterministic oligonucleotide synthesis and assembly system. Instead of relying on random mutations introduced by chemical agents or enzymatic processes, the invention uses precisely controlled oligonucleotide synthesis followed by in vitro assembly to generate protein diversity, substituting random mechanical processes with controlled chemical processes.
2Adaptability or versatility
If large library sizes are constructed to comprehensively explore sequence diversity through mutagenesis, then more variants are available for screening, but resource consumption (manpower and machine resources) increases
Solution Approach 1:
The patent performs preliminary assembly of oligonucleotide sequences in vitro before protein expression, creating a focused pool of potentially functional variants. By pre-assembling and selecting oligonucleotide combinations that are likely to produce functional proteins, the system reduces the need to screen excessively large library sizes, thereby reducing resource consumption while maintaining diversity coverage.
Solution Approach 2:
The patent changes the fundamental parameter of library construction from in vivo mutagenesis to in vitro oligonucleotide assembly. This parameter change allows for precise control over sequence diversity without the stochastic noise of mutagenesis, enabling smaller, more resource-efficient library sizes to achieve the same diversity coverage.
3Reliability
If random mutagenesis strategies are used to optimize affinity, then binding affinity to target may improve, but thermal stability of the FN3 scaffold decreases
Solution Approach 1:
The patent applies local quality by introducing diversity only in specific regions (loops and surface-exposed residues) of the FN3 scaffold while maintaining the conserved core structure. The oligonucleotide pool design targets variable regions that contact the target, allowing affinity optimization through localized sequence variation without compromising the global thermal stability provided by the conserved scaffold framework.
Solution Approach 2:
The patent performs preliminary in silico filtering and in vitro selection of oligonucleotide sequences that are predicted to maintain scaffold stability while providing affinity diversity. By pre-selecting sequences that preserve structural integrity before expression and screening, the system optimizes affinity without inadvertently destabilizing the thermal stability of the FN3 framework.
Data Source
AI summary
Fibronectin libraries useful for efficient screening for specific binding proteins capable of binding a target at high affinity. The libraries, and the resulting binding proteins selected from the libraries, exhibit specific illustrated advantages.